quinazolines has been researched along with benzoxazoles in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Picciola, G | 1 |
Bleasdale, C; Bowman, K; Calvert, AH; Curtin, NJ; Durkacz, BW; Griffin, RJ; Newell, DR; Pemberton, LC; Porteous, JK; Rhodes, D | 1 |
Bekhit, AA; Khalil, MA | 1 |
Bouregeois, NM; Corbett, TH; Crantz, B; Hazeldine, ST; Horwitz, JP; Kushner, J; Palomino, E; Polin, L; White, K | 1 |
Di Paolo, T; Gasparini, F; Gomez-Mancilla, B; Grégoire, L; Hoyer, D; Morissette, M; Ouattara, B | 1 |
Aura, C; Baselga, J; Calvo, MT; García-García, C; Grueso, J; Guzmán, M; Ibrahim, YH; Jessen, K; Liu, Y; Pérez, J; Rommel, C; Scaltriti, M; Serra, V; Tabernero, J | 1 |
Dinneswara Reddy, G; Mallikarjuna Reddy, L; Padmaja, A; Padmavathi, V | 1 |
Lin, J; Xue, L; Yin, S; Zhang, C; Zhou, L | 1 |
Borger, D; Chisholm, S; Foster, R; Growdon, WB; Hernandez, SF; Rueda, BR | 1 |
9 other study(ies) available for quinazolines and benzoxazoles
Article | Year |
---|---|
[Synthesis of quinazolinic and benzoxazinonic acids and study of their anti-inflammatory activity].
Topics: Anti-Inflammatory Agents; Benzoxazoles; Methods; Quinazolines | 1976 |
Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP).
Topics: Animals; Benzoxazoles; Binding Sites; Enzyme Inhibitors; Humans; Leukemia L1210; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines | 1995 |
Non-steroidal anti-inflammatory agents: synthesis of novel benzopyrazolyl, benzoxazolyl and quinazolinyl derivatives of 4(3 H)-quinazolinones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; Granuloma; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Quinazolines; Rats; Rats, Sprague-Dawley | 1998 |
II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
Topics: Animals; Antineoplastic Agents; Benzoxazoles; Drug Screening Assays, Antitumor; Mice; Neoplasm Transplantation; Propionates; Pyrazines; Pyridines; Quinazolines; Quinolines; Quinoxalines; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazines; Tumor Cells, Cultured | 2002 |
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.
Topics: Animals; Antiparkinson Agents; Autoradiography; Benzoxazoles; Brain; Cabergoline; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Female; Imidazoles; Levodopa; Ligands; Macaca fascicularis; MPTP Poisoning; Piperidines; Quinazolines; Receptors, AMPA; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 2010 |
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Benzoxazoles; Blotting, Western; Breast Neoplasms; Cell Cycle; Drug Resistance, Neoplasm; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lapatinib; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Multiprotein Complexes; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Quinazolines; Receptor, ErbB-2; TOR Serine-Threonine Kinases; Transcription Factors; Trastuzumab; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Synthesis and antimicrobial activity of amino linked heterocycles.
Topics: Amines; Anti-Infective Agents; Aspergillus niger; Benzimidazoles; Benzothiazoles; Benzoxazoles; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinazolines; Staphylococcus aureus | 2015 |
Design, synthesis and biological activities of novel oxazolo[4,5-g]quinazolin-2(1H)-one derivatives as EGFR inhibitors.
Topics: Animals; Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Mice; Mice, SCID; Neoplasms, Experimental; Quinazolines; Structure-Activity Relationship | 2015 |
Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoxazoles; Cell Cycle; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Cystadenoma, Serous; Drug Synergism; Female; Gene Amplification; Humans; Lapatinib; Mice; Mice, Inbred NOD; Mice, SCID; Phosphatidylinositol 3-Kinases; Pyrimidines; Quinazolines; Receptor, ErbB-2; Sirolimus; TOR Serine-Threonine Kinases; Trastuzumab; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2016 |